证券记录 · 已归档季度
BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare · Biotechnology
18被追踪持有人
+1Δ持有人
80.75M持有股份
$723.56M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +5.9% ·
股份流向 +17.0% ·
净新建仓位 +5.6%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 474.29K | $3.95M | n/a | n/a |
| Q2 2026 | 107 | +3 | 139.01M | $1.39B | +7 | −5 |
| Q1 2026 | 108 | +4 | 130.67M | $1.24B | +14 | −10 |
| Q4 2025 | 103 | -1 | 127.11M | $991.41M | n/a | −1 |
| Q3 2025 | 22 | +2 | 89.66M | $680.51M | +2 | −1 |
| Q2 2025 | 18 | +1 | 80.75M | $723.56M | +1 | n/a |
| Q1 2025 | 14 | +1 | 26.41M | $198.06M | +1 | n/a |
| Q4 2024 | 13 | -2 | 21.17M | $159.22M | n/a | −2 |
| Q3 2024 | 14 | +4 | 16.62M | $126.32M | +4 | n/a |
| Q2 2024 | 10 | n/a | 15.77M | $97.44M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 21.43M | n/a | $191.98M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (被动) | 20.54M | n/a | $184.08M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 8.51M | +8.9% | $76.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 5.05M | +1.9% | $45.30M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | D. E. Shaw & Co. ✦ | 4.39M | +176.2% | $39.33M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Two Sigma Investments ✦ | 4.29M | +109.6% | $38.42M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 4.28M | +2103.7% | $38.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 2.78M | -8.8% | $24.93M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 2.56M | +345.4% | $22.91M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 2.53M | +317.5% | $22.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.91M | -50.0% | $17.08M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.15M | -4.4% | $10.29M | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
| 13 | Fidelity (FMR) ✦ | 655.89K | n/a | $5.88M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | Gotham Asset Management ✦ | 201.81K | +358.0% | $1.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 146.64K | +9.2% | $1.31M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Marshall Wace ✦ | 143.31K | 新增 | $1.28M | 0.0% | New | 1 | SEC ↗ ×2 |
| 17 | Norges Bank ✦ (被动) | 111.15K | -61.4% | $995,922 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Wellington Management ✦ | 86.78K | -5.0% | $777,531 | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $1.28M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 298 持有人, 245.96M 股份, $2.30B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A: RA CAPITAL MANAGEMENT, L.P.
Aug 07
SC 13G: STATE STREET CORP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据